M

Diketahui :

Total Population : 230000000

FIXED COST in 5 yrs

Manufacture $ 1,200,000 $ 6,000,000
Marketing $ 23,000,000 $ 23,000,000
RnD Metabical $ 400,000,000 $ 400,000,000
TOTAL $ 424,200,000 $ 429,000,000

Scenario 1 : Approaching Ov

BMI 25-30 34% 78200000

Trying to Lose Weight 35% 27370000
Potential User 15% 4105500
Target Market 4105500

Forecast for 5 Years

Year 1 2 3
10% 15% 20%
First Time User
410550 615825 821100
Repurchase Second Supply 60% 246330 369495 492660
Finished Program 20% 49266 73899 98532
TOTAL 706146 1059219 1412292
Amount Total of Metabical Pill Forecast $ 88,268,250.00 $ 132,402,375.00 $ 176,536,500.00
Growth Sales 50% 33%

Scenario 2: Using Th

BMI 25-30 34% 78200000

Ready to Request Prescription 12% 9384000
Target Market 9384000

Forecast for 5 Years

Years 1 2 3
10% 15% 20%
First Time User
938400 1407600 1876800
Repurchase Second Supply 60% 563040 844560 1126080
Finished Program 20% 112608 168912 225216
TOTAL 1614048 2421072 3228096
Amount Total of Metabical Pill Forecast $ 201,756,000.00 $ 302,634,000.00 $ 403,512,000.00
Growth Sales 50% 33%

Scenario 3 : Focused

Ideal Target 4300000

Target Market 4300000

Forecast for 5 Years

Years 1 2 3
30% 35% 40%
First Time User
1290000 1505000 1720000
Repurchase Second Supply 60% 774000 903000 1032000
Finished Program 20% 154800 180600 206400
TOTAL 2218800 2588600 2958400
Amount Total of Metabical Pill Forecast $ 277,350,000.00 $ 323,575,000.00 $ 369,800,000.00
Growth Sales 17% 14%

KESIMPULAN

Berdasarkan Forecast diatas, target market terbesar yang dapat disasar oleh Metabical ialah Skenario 2 dengan menyasar O
di US. Jika diperhatikan, ROI dari Value of Customer memang memiliki presentase besar namun perlu diingat bahwa cu
overweight ini tidak semua memiliki daya beli di harga tersebut, sehingga skenario terbaik yang dapat diambil iala
 METABICAL FORECAST

Scenario 1 : Approaching Overweight Individual in US : (BMI 25-30)

Price Comparison
4 5
25% 30%
1026375 1231650 Profit price
615825 738990 Demand (5 th)
123165 147798 Total Sales
1765365 2118438 7061460 ROI
$ 220,670,625.00 $ 264,804,750.00 $ 882,682,500.00
25% 20%

Scenario 2: Using The Results From The CSP survey

Price Comparison
4 5
25% 30%
2346000 2815200 Profit price
1407600 1689120 Demand (5 th)
 281520 337824 Total Sales
4035120 4842144 16140480 ROI
$ 504,390,000.00 $ 605,268,000.00 $ 2,017,560,000.00
25% 20%

Scenario 3 : Focused On The Ideal Target Consumer

Price Comparison
4 5
45% 50%
1935000 2150000 Profit price
1161000 1290000 Demand (5 th)
232200 258000 Total Sales
3328200 3698000 14792000 ROI
$ 416,025,000.00 $ 462,250,000.00 $ 1,849,000,000.00
13% 11%

Skenario 2 dengan menyasar Overweight Individu

namun perlu diingat bahwa customer segmen
erbaik yang dapat diambil ialah skenario 2
 Ali CSP Drug Value of Customer
$ 75 $ 125 $ 150
7061460 7061460 7061460
529609500 882682500 1059219000
23% 106% 147%

Ali CSP Drug Value of Customer

$ 50 $ 83 $ 100
16140480 16140480 16140480
 $ 807,024,000 $ 1,344,986,198 $ 1,614,048,000
88% 214% 276%

Ali CSP Drug Value of Customer

$ 50 $ 83 $ 150
14792000 14792000 14792000
$ 739,600,000 $ 1,232,617,360 $ 2,218,800,000
72% 187% 417%